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Hsp27 oligomer is reported to interact with F-actin as a barbed-end-capping protein. The present study determined the binding
strength and stoichiometry of the interaction using ﬂuorescence of probes attached to Hsp27 cysteine-137. The ﬂuorescence
of acrylodan attached to Hsp27 increased 4-5-fold upon interaction with F-actin. Titration of the ﬂuorescence with F-actin
yielded a weak binding constant (K
app
D = 5.3μM) with an actin/Hsp27 stoichiometry between <1 and 6. This stoichiometry is
inconsistent with an F-actin end-capping protein. Pyrene attached to Hsp27 exhibited a large excimer ﬂuorescence, in agreement
with the known proximity of the cysteine-137’s in the Hsp27 oligomer. Upon interaction with F-actin the pyrene-Hsp27 excimer
ﬂuorescence was largely lost, suggesting that Hsp27 interacts with F-actin as a monomer, consistent with the acrylodan-Hsp27
results. EM images of F-actin-Hsp27 demonstrated that Hsp27 is not a strong G-actin sequester. Thus, Hsp27, in vitro, is a weak
F-actin side-binding protein.
1.Introduction
Mammalian heat shock protein 27 (Hsp27) is a member of
a family of small heat shock proteins that includes the eye
lens protein αB-crystallin, the archetype of the family [1–
3]. These proteins form oligomeric structures and share a
conserved α-crystallin domain responsible for intersubunit
β-strand-β-strand interactions in the basic dimer subunit.
Under physiological conditions Hsp27 occurs as a polydis-
perse distribution of oligomers centered about a minimum
22mer[4].Hsp27isinvolvedinavarietyofcellularfunctions
including molecular chaperone activity, control of apoptosis,
and regulation of the actin ﬁlament cytoskeleton [1–3, 5–9].
Actinisoneofthemostabundantproteins,thatispresent
in almost all eukaryotic cells. The actin ﬁlament (F-actin) is
composed of actin monomers (G-actin) polymerized head-
to-tail to form two intertwining helical strands, resulting
in a polar ﬁlament with a “barbed end” and a “pointed
end” [10]. Actin ﬁlaments are part of the cytoskeleton and
their dynamic structure is involved in the motility and shape
change of the cell [10]. Hsp27 has been implicated in numer-
ous physiological and pathological processes that involve its
interaction with actin and its control of actin dynamics [11–
25]. However, the mechanism of the interaction between
Hsp27 and actin is unclear and controversial and a binding
study of the interaction between the two proteins in vitro
has not been reported [3]. An early study of the Hsp25
(murine and avian isoform of Hsp27)—actin interaction
concluded that Hsp25 was an actin ﬁlament barbed-end-
capping protein based on limited evidence [26]. Since that
study it has generally been assumed that Hsp25 and Hsp27
are actin barbed-end-capping proteins, although there has
been little further support for this interaction model. It is
also unknown if Hsp27 interacts with the actin ﬁlament as
a monomer, dimer, or higher multimer.
In order to address some of these issues we have inves-
tigated the interaction between Hsp27 and actin, in vitro,
using ﬂuorescence probes attached to Hsp27. We concluded
that Hsp27, although an oligomer in solution, binds to
the actin ﬁlament, most likely, as a monomer, with an
actin monomer/Hsp27 molar stoichiometry between <1a n d
6.SuchastoichiometrydoesnotsupporttheviewthatHsp27
is simply an actin ﬁlament end-capping protein. Instead,
we propose that Hsp27 binds along the side of the F-actin
ﬁlament.2 Biochemistry Research International
2.MaterialsandMethods
2.1. Preparation of Hsp27 and Actin. Full-length Hsp27 was
prepared by bacterial expression and puriﬁcation using
the New England Biolabs IMPACT-CN intein system, as
described previously [4]. The advantage of using the intein
expression system is that no extraneous N- or C-terminal
residues are introduced. Additional N-terminal amino acids
in expressed Hsp27 have been shown to alter the oligomeric
structure of Hsp27 and other small heat shock proteins
[27, 28]. The puriﬁed Hsp27 was concentrated by Milli-
pore/Amicon Ultra centrifugal ﬁlter devices, then dialyzed
and stored on ice in 2mM Mops, 0.1mM EDTA, 0.01%
NaN3,5 0μMP M S F ,p H7 . 5( B u ﬀer A). Hsp27 concentration
was determined from the absorbance at 280nm, after
subtracting the absorbance at 320nm, using an extinction
coeﬃcient of A0.1%
280nm = 1.65cm−1. Actin was prepared as
reported [29] from rabbit skeletal muscle and stored for up
to two weeks on ice as the actin monomer in G-buﬀer (2mM
Mops, 0.2mM CaCl2, 0.2mM ATP, 0.01% NaN3,p H7 . 5 ) .
Actin concentration was determined from the absorbance at
290nm minus that at 320nm using an extinction coeﬃcient
A1%
290nm = 6.3cm−1 [30]. G-actin was polymerized to F-actin
byaddingNaClandMgCl2 to40mMand2mM,respectively
(F-buﬀer).
2.2. Fluorescence Labeling of Hsp27. The sulfhydryl reactive
ﬂuorescent probes acrylodan (6-acryloyl-2-(dimethylami-
no)naphthalene) (AC) and pyrene iodoacetamide (N-(1-
pyrene)iodoacetamide) were purchased from Molecular
Probes (Invitrogen). The single cysteine (Cys137) of Hsp27
was labeled with the above probes for several hours at 37◦C
as described for other probes [31]. Brieﬂy, Hsp27 in Buﬀer A
was reacted with a 2.5-fold molar excess of acrylodan for 3hr
or a 10-fold molar excess of pyrene-iodoacetamide for 5hr
at 37◦C. The reaction was stopped with 5mM DTT, followed
by dialysis versus Buﬀer A to remove dissolved excess label,
after centrifuging pyrene-Hsp27 to pellet the suspended,
unreacted pyrene-iodoacetamide probe. The labeling ratios
were determined by measuring the labeled Hsp27 concen-
tration with the BCA protein assay [32] using unlabeled
Hsp27 as a standard and measuring the attached acrylodan
and pyrene concentrations from the optical absorbance with
extinction coeﬃcients ε360nm = 12,900M−1cm−1[33]a n d
ε343nm = 22,000M−1cm−1 [34], respectively. The ﬁnal molar
labeling ratios (probe/Hsp27) were between 0.6–1.0 for
pyrene-Hsp27 and 0.8–1.1 for acrylodan-hsp27.
2.3. Hsp27-Actin Interaction by Fluorescence Spectroscopy.
Fluorescence measurements were made on a Varian Eclipse
ﬂuorometer equipped with a Varian Peltier device for tem-
perature control. Fluorescence measurements of acrylodan-
Hsp27 and pyrene-Hsp27 were made at excitation wave-
lengths of 395nm and 342nm, respectively. For ﬂuorescence
titration of acrylodan-Hsp27 with F-actin at diﬀerent con-
centrations,separatesamplesweremadeupforeachtitration
point and incubated overnight at 37◦Cb e f o r es p e c t r aw e r e
recorded. From the spectra, the ﬂuorescence intensity was
determined at 485nm and plotted versus the total actin con-
centration.
The data are analyzed according to a simple binding
equation, nA + B = AnB where A is the actin protomer in F-
actin, B is Hsp27 irrespective of its oligomeric state, and n is
the actin/Hsp27 molar binding stoichiometry. The binding
is described by the equation: nbφ2− (KD+n b+a ) φ +a
= 0 where b is the total concentration of Hsp27 which is
held constant, a is the total concentration of actin which is
varied,KD isthedissociationconstant,and φ isthefractional
saturation of binding sites, i.e. [AB]/nb, which is equal to
the fractional increase in ﬂuorescence enhancement and is a
rootofthequadraticsolutiontotheaboveequation.Onecan
extractnandKD byﬁttingaquadraticsolutiontothebinding
equation to the data points using an unweighted, nonlinear
least squares ﬁtting procedure [35, 36].
2.4. Electron Microscopy of F-Actin ± Hsp27. F-actin at
150μM was diluted to 2μM in F-buﬀer. To some samples
Hsp27wasaddedto6μMandincubatedfor120minatroom
temperature, followed by overnight at 4◦C and 120min at
room temperature. Samples were then applied to a carbon-
ﬁlm coated copper grid, negatively stained with 1% aqueous
uranyl acetate and observed under a Philips 300 electron
microscope at 60kV.
2.5. Analytical Ultracentrifugation. Analytical ultracentrifu-
gation sedimentation velocity was run and the resulting data
w a sa n a l y z e da sd e s c r i b e d[ 4].
3. Results
The direct binding of a protein to F-actin ﬁlaments is
generally determined by cosedimentation of the ﬁlaments
with bound protein, followed by SDS-PAGE of the pellet
and supernatant. However, Hsp27 is a large oligomeric pro-
tein which also sediments, independently of actin binding,
making this technique problematic. Therefore we took an
alternative approach by using Hsp27 labeled with a ﬂuo-
rescence probe whose signal is sensitive to the binding of
actin. Two cysteine-speciﬁc ﬂuorescence probes, acrylodan
and pyrene-iodoacetamide, attached to the single cysteine
(Cys137) of Hsp27 fulﬁlled this requirement.
3.1.Acrylodan-HSP27. Inordertodeterminetheeﬀectofthe
acrylodan probe on Hsp27 quaternary structure, analytical
ultracentrifugation sedimentation velocity of acrylodan-
Hsp27 (AC-Hsp27) was compared to that of unlabeled
Hsp27 over a range of concentrations (Figure 1). No signiﬁ-
cantdiﬀerencewasfound.BothlabeledandunlabeledHsp27
had almost identical sedimentation coeﬃcients of close
to 20 svedbergs (Figure 1), a value in agreement with our
previous conclusion that Hsp27 is an oligomeric distribution
centered around a minimum size of a 22-mer [4]. Thus
placing a probe at Cys137 does not signiﬁcantly perturb the
oligomeric structure of Hsp27.
Acrylodan is very sensitive to its environment [33] and,
when attached to a protein, often sensitive to protein-proteinBiochemistry Research International 3
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Figure 1: Weight average sedimentation coeﬃcient, corrected to
20◦Cinwater,versusconcentrationofHsp27(closedcircles)orAC-
Hsp27 (open squares). Buﬀer = 120mMNaCl,25mMT ris,2mM
MgCl2, 0.2mM EGTA, 0.01% NaN3,5 0μMP M S F ,5m MD T T ,a n d
pH 7.5. The standard deviation of the data points is propagated
from the noise in the original data set as described [37].
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Figure 2: Eﬀect of F-actin on the ﬂuorescence spectrum of AC-
Hsp27. AC-Hsp27 (1μM) at 37◦Ci nF - b u ﬀer in the absence (closed
circles) and presence (open circles) of 40μM F-actin after overnight
incubation at 37◦C.
interaction. As shown in Figure 2, acrylodan-Hsp27 is very
sensitive to the binding to F-actin. In the presence of actin
the ﬂuorescence intensity increased about 4-5-fold and the
emission spectrum was blue-shifted about 20nm (Figure 2),
changesindicativeofgreaterprobeshieldingfromthesolvent
upon interaction with actin.
In order to determine the strength and stoichiometry of
the binding, the ﬂuorescence enhancement of a ﬁxed con-
centration of acrylodan-Hsp27 was titrated with increasing
concentrations of F-actin at 37◦C. For this determination
acrylodan-Hsp27 was incubated with F-actin overnight at
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Figure 3: Fluorescence versus time of AC-Hsp27 plus F-actin.
Fluorescence at 485nm of 1μM AC-Hsp27 versus time after
addition of 40μM F-actin in F-buﬀer at 37◦C. The saturated
ﬂuorescence value of 432 ± 6 ﬂuorescence units was obtained from
an unweighted, nonlinear least squares double exponential ﬁt of the
data points and the root mean square deviation of the points from
the ﬁt.
37◦C in order to insure complete equilibration. This was
necessarysinceuponadditionofF-actintoacrylodan-Hsp27
the acrylodan ﬂuorescence increased slowly after an initial
relatively rapid rise (Figure 3). After overnight at 37◦C there
was no further change in ﬂuorescence intensity for at least
5 hours. The slow equilibration could be best ﬁt with two
exponentials (Figure 3) suggesting that at least two processes
are taking place.
The titration of acrylodan-Hsp27 ﬂuorescence intensity
with F-actin was best ﬁt with an apparent dissociation
constant of K
app
D = 5.3μM ± 0.6 (Figure 4), ﬁxing the
actin/Hsp27 molar stoichiometry at 1.0, indicating a rather
weak interaction. Because the Hsp27-actin binding is not
strong, the stoichiometry is somewhat uncertain in that the
data can be ﬁt with an actin/Hsp27 molar stoichiometry
value of between <1 and 6 with a 90% conﬁdence level using
F-statistics on χ2 values. The dissociation constant varies
between 3.0 and 5.6μM over this range of stoichiometries.
The ﬁt deteriorates for stoichiometries of greater than 6 in
thatχ2 valuescontinuetoincrease.Theseresultsindicatethat
Hsp27 binds to actin all along the actin ﬁlament, each Hsp27
monomer interacting with between <1 and 6 actin subunits.
Indeed, Hsp27 is an elongated molecule [4] which could well
cover at least two actin subunits. A stoichiometry of less than
1 would indicate several Hsp27 molecules interacting with
eachactinmoleculeintheactinﬁlament.Thislattersituation
would be limited by physical crowding of Hsp27 molecules
along the ﬁlament.
These results rule out that Hsp27 is binding to actin
simply as a barbed-end-capping protein. The average length
ofanactinﬁlamentpolymerizedinvitroisabout6.7μm[38],
equivalent to about 2500 actin subunits. Thus an Hsp27 22-
mer [4] bound at the barbed end of each ﬁlament would4 Biochemistry Research International
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Figure 4: Fluorescence of AC-Hsp27 titrated with F-actin. Percent
ﬂuorescence enhancement at 485nm as a function of actin con-
centration in F-buﬀer at 37◦C. AC-Hsp27 = 1μM. The best ﬁt of
the data yielded an apparent dissociation constant K
app
D = 5.3 ±
0.6μM with the actin/Hsp27 molar stoichiometry ﬁxed at 1.0. The
error in K
app
D is calculated from the root mean square deviation of
data points from the ﬁt.
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Figure 5: Fluorescence spectrum of pyrene-Hsp27 upon interac-
tion with F-actin. Pyrene-Hsp27 (1μM) in the absence (blue closed
circles) and presence (red open circles) of 5-fold molar excess of F-
actin at 37◦Ci nF - b u ﬀer.
result in an actin/Hsp27 molar stoichiometry of greater
than 100. For smaller oligomers the stoichiometry would be
higher, all values much larger than we have estimated from
the ﬂuorescence titration in Figure 4.
3.2. Pyrene-HSP27. Although we have ruled out that Hsp27
binds to actin simply as an end-capping protein from the
acrylodan-Hsp27 results, the results do not allow us to
know the size of the Hsp27 that is bound to actin. That is,
does it bind to actin as a monomer, a dimer, or a larger
multimer? We have used the ﬂuorescence of pyrene-Hsp27
to aid us in this determination. The pyrene probe can be a
proximity probe, in that when two pyrene moieties are in
close proximity they may stack in the excited state which
results in an excited state dimer, called an excimer. Pyrene
excimer ﬂuorescence is a broad band centered around
500nm, quite diﬀerent from the narrower doublet band
of the pyrene monomer moiety centered at about 400nm
[39, 40].
Cys137 of Hsp27 (Cys141 of Hsp25) has been shown to
be close to Cys137 of a neighboring Hsp27 molecule in the
basic dimeric building block of the Hsp27 oligomer by spin-
spin ESR spectroscopy [41, 42] and by disulﬁde cross-linking
[26, 42–44]. We thought that we might be able to exploit
pyrene excimer ﬂuorescence to monitor this interaction. In
agreement with this proximity the ﬂuorescence spectrum
of pyrene-Hsp27 showed a relatively intense excimer band
compared to that of the band of the pyrene monomer
(Figure 5). Upon interaction with F-actin the intensity of the
excimer ﬂuorescence of pyrene-Hsp27 dropped dramatically
with a smaller concomitant increase in that of the pyrene
monomer (Figure 5). The remaining excimer ﬂuorescence in
the presence of actin is most likely due to pyrene-Hsp27 that
is not bound to actin since the 5-fold molar excess of actin
used in this experiment is not suﬃcient to complex all of
the Hsp27 (Figure 4). The concentration of F-actin used was
limited by its Rayleigh light scattering which overlaps with
the pyrene monomer band. Therefore it is clear that, upon
bindingofpyrene-Hsp27toF-actin,theexcimerﬂuorescence
is almost entirely lost and this loss is most likely due to
a dissociation of pyrene-Hsp27 into monomer molecules
attached to actin and thus no longer able to form excimers.
These results, together with those of AC-Hsp27, are con-
sistent with Hsp27 binding to actin as a monomer with an
actin/Hsp27 molar stoichiometry between <1a n d6 .
However we cannot entirely rule out that the loss in
pyrene-Hsp27 excimer ﬂuorescence upon actin binding is
due to a conformational change around Cys137 such that
pyrene moieties are no longer able to properly stack for
excimer formation. In that case the results would also be
consistentwithapyrene-Hsp27bindingtoF-actinasadimer
or a multimer with the loss of excimer due to a long-range
allosteric conformational change in Hsp27 resulting in the
loss of excimer.
3.3. Electron Microscopy of the Actin-HSP27 Complex. It
has been concluded from indirect evidence that Hsp27 is
a strong actin monomer sequestering protein [24]. It was
calculated that 3-4 actin monomers bound tightly to each
Hsp27 monomer within the Hsp27 oligomer, with a dis-
sociation constant of 20nM [24]a t2 5 ◦C. In order to rule
out such an interaction accounting for our ﬁndings we
observed electron microscopic images of F-actin ﬁlaments
in the absence and presence of a threefold molar excess of
Hsp27 under the F-actin ionic conditions used above. Strong
Hsp27 sequestration of actin monomers in equilibrium with
actin ﬁlaments would result in a dissolution of the ﬁlaments
upon incubation of the ﬁlaments with Hsp27. Our electron
microscopic images (Figure 6) showed that, although Hsp27
results in some aggregation of F-actin ﬁlaments, there is noBiochemistry Research International 5
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Figure 6:ElectronmicroscopyofF-actin ±Hsp27.Negativestainingimagesof2μMactin(a)and2μMactinplus6μMHsp27(b)incubated
overnight in F-buﬀer. Magniﬁcation equals x 15960. Images courtesy of Dr. Katsuhide Mabuchi.
signiﬁcant dissolution of the ﬁlaments, indicating no sig-
niﬁcant actin monomer sequestration by Hsp27. Thus such
a mechanism cannot account for our ﬂuorescence observa-
tions above.
4. Discussion
This study investigated the equilibrium binding parameters
of the in vitro interaction between Hsp27 and F-actin and
concluded that, in vitro, Hsp27 is not a simple actin barbed-
end-capping protein, as is generally assumed. Rather, it is
concluded that Hsp27 binds weakly along the side of the
actin ﬁlament as a monomer with an actin/Hsp27 molar
ratio between <1 and 6. A previous work also concluded that
monomeric but not oligomeric Hsp25 interacted with actin
[45]. However, we cannot entirely rule out that Hsp27 is a
barbed-end-capping protein in addition to being an actin
side-binding protein, which has been shown to be the case
for another actin-binding protein, vinculin [46].
The ﬁtting of the binding data assumes a rather simple
binding model of Hsp27 monomer in solution in equilib-
rium with actin-bound Hsp27. However, Hsp27 is primarily
an oligomer in solution [4]; therefore the apparent dissoci-
ation constant from the ﬁt reﬂects the diﬀerence in binding
between Hsp27 monomer bound to the oligomer compared
to its binding to the actin ﬁlament. Thus we can only
conclude that Hsp27 binds weakly to actin compared to its
bindingtoitselfintheHsp27oligomer.Thestrongbindingof
Hsp27 to itself might reﬂect a slow rate of dissociation of the
monomer (or dimer) from the Hsp27 oligomer and account,
at least in part, for the slow attainment of equilibrium of its
binding to actin. Alternatively, the ﬁrst step in the binding
sequence might be the attachment of the Hsp27 oligomer
to the actin ﬁlament which then slowly “peels oﬀ” Hsp27
monomers.
Another work has also concluded that Hsp27 is not a
barbed-end-capping protein by the eﬀect of Hsp27 on actin
polymerization properties [24]. That work concluded that
Hsp27 is primarily a strong actin monomer sequestering
protein, tightly binding 3-4 actin monomers per Hsp27
molecule in the Hsp27 oligomer [24]. However, our electron
microscopic images of F-actin plus Hsp27 demonstrate that
Hsp27 does not dissolve actin ﬁlaments and thus is not a
strong actin monomer sequestering protein. Another recent
work has also concluded, from actin polymerization studies,
that Hsp27 is ineﬃcient in sequestering actin monomers in
the presence of actin ﬁlaments [47]. That work [47] and the
present work employ Hsp27 without any extra residues at
either end of the molecule whereas the previous work [24]
used Hsp27 with extra residues at the N-terminus. It has
been shown that extra N-terminal residues can modify the
oligomeric structure of Hsp27 and other similar small heat
shockproteinsandthuspossiblymodifyitsfunction[27,28].
This might be the source of the above discrepancies.
Inconclusion,invitro,Hsp27isnotasimplebarbed-end-
capping protein but instead primarily binds to the sides of
the actin ﬁlament. Compared to its binding to itself in the
Hsp27oligomer,Hsp27bindsweaklytoactin.Thefunctional
consequence of such a weak and slow-to-reach-equilibrium
interaction awaits further investigation.
Abbreviations
Hsp27: Heat shock protein 27
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